Phistem ^None

Phistem is a company that was established in 2009 with the aim of discovering and creating small molecules and other substances that can affect the signaling pathways involved in communication between cells in stem cells and cancer stem cells. They specialize in identifying compounds that can either enhance healing or destroy cancer stem cells by targeting these pathways. Phistem has developed a specific expertise in drug screening and development to efficiently find the most effective compounds.